Efficacy and safety of pegylated interferon-alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.

Miguel Santin; Evelyn Shaw; M Jose Garcia; Antonio Delejido; Eduardo Rodriguez de Castro; Rosa Rota; Jordi Altés; Francisco Baguena; Silvia Valero; Montserrat Sala

doi:10.1089/aid.2006.22.315

Efficacy and safety of pegylated interferon-alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.

Identifier:nobleid.org/w1/20260515/F5CF2FAD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F5CF2FAD.svg?ark=w1%2F20260515%2FF5CF2FAD)](https://nobleid.org/work/w1/20260515/F5CF2FAD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Eduardo Rodriguez de Castro

Claim authorship of this work

Efficacy and safety of pegylated interferon-alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.

Identifier:nobleid.org/w1/20260515/F5CF2FAD

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F5CF2FAD.svg?ark=w1%2F20260515%2FF5CF2FAD)](https://nobleid.org/work/w1/20260515/F5CF2FAD)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Eduardo Rodriguez de Castro

Claim authorship of this work